Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name RBN-2397
Trade Name
Synonyms RBN2397|Atamparib
Drug Descriptions

RBN-2397 is a small molecule inhibitor that targets PARP7, potentially inducing type I interferon signaling, which may lead to an immune response and tumor regression (PMID: 34375612).

CAS Registry Number 2381037-82-5
NCIT ID C170764


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Pembrolizumab + RBN-2397 Pembrolizumab RBN-2397 0 1
RBN-2397 RBN-2397 0 1

Additional content available in CKB BOOST